Literature DB >> 9199319

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

H Aktas1, H Cai, G M Cooper.   

Abstract

Activation of growth factor receptors by ligand binding initiates a cascade of events leading to cell growth and division. Progression through the cell cycle is controlled by cyclin-dependent protein kinases (Cdks), but the mechanisms that link growth factor signaling to the cell cycle machinery have not been established. We report here that Ras proteins play a key role in integrating mitogenic signals with cell cycle progression through G1. Ras is required for cell cycle progression and activation of both Cdk2 and Cdk4 until approximately 2 h before the G1/S transition, corresponding to the restriction point. Analysis of Cdk-cyclin complexes indicates that Ras signaling is required both for induction of cyclin D1 and for downregulation of the Cdk inhibitor p27KIP1. Constitutive expression of cyclin D1 circumvents the requirement for Ras signaling in cell proliferation, indicating that regulation of cyclin D1 is a critical target of the Ras signaling cascade.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199319      PMCID: PMC232237          DOI: 10.1128/MCB.17.7.3850

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

2.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.

Authors:  J J Liu; J R Chao; M C Jiang; S Y Ng; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

3.  Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation.

Authors:  Y Terada; M Tatsuka; S Jinno; H Okayama
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

4.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Authors:  I Reynisdóttir; K Polyak; A Iavarone; J Massagué
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

5.  Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.

Authors:  C Albanese; J Johnson; G Watanabe; N Eklund; D Vu; A Arnold; R G Pestell
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

6.  Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

Authors:  J Lukas; J Bartkova; M Rohde; M Strauss; J Bartek
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

9.  Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.

Authors:  D Resnitzky; L Hengst; S I Reed
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

Authors:  P Steiner; A Philipp; J Lukas; D Godden-Kent; M Pagano; S Mittnacht; J Bartek; M Eilers
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  99 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation.

Authors:  S Poser; S Impey; K Trinh; Z Xia; D R Storm
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

4.  The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB.

Authors:  Zoe A Felton-Edkins; Jennifer A Fairley; Emma L Graham; Imogen M Johnston; Robert J White; Pamela H Scott
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

5.  Recruitment of Cdc28 by Whi3 restricts nuclear accumulation of the G1 cyclin-Cdk complex to late G1.

Authors:  Hongyin Wang; Eloi Garí; Emili Vergés; Carme Gallego; Martí Aldea
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

6.  Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Gudrun Ziegeler; Jie Ming; Jana C Koseki; Sema Sevinc; Ting Chen; Suleyman Ergun; Xuebin Qin; Bertal H Aktas
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

7.  Fos family members induce cell cycle entry by activating cyclin D1.

Authors:  J R Brown; E Nigh; R J Lee; H Ye; M A Thompson; F Saudou; R G Pestell; M E Greenberg
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 8.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 9.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

10.  SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.

Authors:  Nathan J Schuld; Andrew D Hauser; Adam J Gastonguay; Jessica M Wilson; Ellen L Lorimer; Carol L Williams
Journal:  Cell Cycle       Date:  2014-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.